Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 35, Issue 1, 2015, Pages 58-63

  Yang, Feng jie ^a   He, Yong hua ^a   Zhou, Jian hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

activating phosphoinositide 3 kinase protein kinase B; Fenofibrate; inflammation; renal ischemia reperfusion injury

Indexed keywords

FENOFIBRATE; PHOSPHATIDYLINOSITOL 3 KINASE; PRIMER DNA; PROTEIN KINASE B;

ANIMAL; C57BL MOUSE; ENZYME ACTIVATION; INFLAMMATION; KIDNEY; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENZYME ACTIVATION; FENOFIBRATE; INFLAMMATION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84922534932     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1389-2     Document Type: Article

References (22)

1. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med, 1998, 128(3):194–203
2. Aydin Z, van Zonneveld AJ, de Fijter JW, et al. New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant, 2007, 22(2):342–346
3. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol, 2005, 16(11):3365–3370
4. Kazmers A, Jacobs L, Perkins A. The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res, 1997, 67(1):62–66
5. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA, 1996, 275(19):1489–1494
6. Zhang J, Li JH, Wang L, et al. Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(4):516–520
7. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med, 2002, 346(5): 305–310
8. Amura CR, Renner B, Lyubchenko T, et al. Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol, 2012, 52(3–4):249–257
9. Fan LH, He L, Cao ZQ, et al. Effect of ischemia preconditioning on renal ischemia/reperfusion injury in rats. Int Braz J Urol, 2012, 38(6):842–854
10. Kusch A, Hoff U, Bubalo G, et al. Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf), 2013, 208(1):25–40
11. Kim HJ, Joe Y, Kong JS, et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev, 2013, 2013:306421
12. Hofmann BT, Jucker M. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85alpha regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Cell Signal, 2012, 24(10):1950–1954
13. Chen L, Wei X, Hou Y, et al. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3beta pathway in rats. Neurochem Int, 2014, 66:27–32
14. Rasin MS. Peroxisome proliferator-activated receptors-gamma and hypertension: lessons of the history of researches. Ter Arkh, 2013, 85(9):118–123
15. Guebre-Egziabher F, Alix PM, Koppe L, et al. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie, 2013, 95(11):1971–1979
16. Bulhak AA, Jung C, Ostenson CG, et al. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol, 2009, 296(3):H719–727
17. Patel NS, di Paola R, Mazzon E, et al. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J Pharmacol Exp Ther, 2009, 328(2):635–643.
18. Dong C, Hu Y, Wang H, et al. Inhibitory effects of fenofibrate on plasminogen activator inhibitor-1 expression in human endothelial cells. Huazhong Univ Sci Technolog Med Sci, 2006, 26(2):192–193
19. Retraction note: Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, on hepatic ischemia-reperfusion injury in rats. J Mol Histol, 2013, 44(4):495
20. Yang C, Zhao T, Lin M, et al. Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood), 2013, 238(1):111–119
21. Xie L, Zheng X, Qin J, et al. Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton), 2006, 11(3):207–212
22. Liu WH, Liu HB, Gao DK, et al. ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway. Cell Transplant, 2013, 22(10):1859–1868